Raman spectroscopic analysis of skin as a diagnostic tool for Human African Trypanosomiasis
Authors:
Open Access
- 15 November 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (11) , e1010060
Abstract
Human African Trypanosomiasis (HAT) has been responsible for several deadly epidemics throughout the 20th century, but a renewed commitment to disease control has significantly reduced new cases and motivated a target for the elimination of Trypanosoma brucei gambiense-HAT by 2030. However, the recent identification of latent human infections, and the detection of trypanosomes in extravascular tissues hidden from current diagnostic tools, such as the skin, has added new complexity to identifying infected individuals. New and improved diagnostic tests to detect Trypanosoma brucei infection by interrogating the skin are therefore needed. Recent advances have improved the cost, sensitivity and portability of Raman spectroscopy technology for non-invasive medical diagnostics, making it an attractive tool for gambiense-HAT detection. The aim of this work was to assess and develop a new non-invasive diagnostic method for T. brucei through Raman spectroscopy of the skin. Infections were performed in an established murine disease model using the animal-infective Trypanosoma brucei brucei subspecies. The skin of infected and matched control mice was scrutinized ex vivo using a confocal Raman microscope with 532 nm excitation and in situ at 785 nm excitation with a portable field-compatible instrument. Spectral evaluation and Principal Component Analysis confirmed discrimination of T. brucei-infected from uninfected tissue, and a characterisation of biochemical changes in lipids and proteins in parasite-infected skin indicated by prominent Raman peak intensities was performed. This study is the first to demonstrate the application of Raman spectroscopy for the detection of T. brucei by targeting the skin of the host. The technique has significant potential to discriminate between infected and non-infected tissue and could represent a unique, non-invasive diagnostic tool in the goal for elimination of gambiense-HAT as well as for Animal African Trypanosomiasis (AAT).Keywords
Funding Information
- Wellcome Trust (209511/Z/17/Z)
- University of Strathclyde
- Sir Henry Wellcome Postdoctoral Fellowship (221640/Z/20/Z)
This publication has 62 references indexed in Scilit:
- Mosaic VSGs and the Scale of Trypanosoma brucei Antigenic VariationPLOS Pathogens, 2013
- Proteomic Selection of Immunodiagnostic Antigens for Human African Trypanosomiasis and Generation of a Prototype Lateral Flow Immunodiagnostic DevicePLOS Neglected Tropical Diseases, 2013
- Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)The Lancet Neurology, 2013
- Estimating and Mapping the Population at Risk of Sleeping SicknessPLOS Neglected Tropical Diseases, 2012
- Diagnostic Accuracy of Molecular Amplification Tests for Human African Trypanosomiasis—Systematic ReviewPLOS Neglected Tropical Diseases, 2012
- Revisiting the Immune Trypanolysis Test to Optimise Epidemiological Surveillance and Control of Sleeping Sickness in West AfricaPLOS Neglected Tropical Diseases, 2010
- Lipid metabolism in Trypanosoma bruceiMolecular and Biochemical Parasitology, 2010
- Lipidomic analysis of bloodstream and procyclic formTrypanosoma bruceiParasitology, 2010
- Direct analysis of clinical relevant single bacterial cells from cerebrospinal fluid during bacterial meningitis by means of micro‐Raman spectroscopyJournal of Biophotonics, 2009
- The Burden of Human African TrypanosomiasisPLOS Neglected Tropical Diseases, 2008